AU8624698A - DNA sequences, expression of these DNA sequences, thermophilic laccases encoded by the DNA sequences, and the use thereof - Google Patents
DNA sequences, expression of these DNA sequences, thermophilic laccases encoded by the DNA sequences, and the use thereof Download PDFInfo
- Publication number
- AU8624698A AU8624698A AU86246/98A AU8624698A AU8624698A AU 8624698 A AU8624698 A AU 8624698A AU 86246/98 A AU86246/98 A AU 86246/98A AU 8624698 A AU8624698 A AU 8624698A AU 8624698 A AU8624698 A AU 8624698A
- Authority
- AU
- Australia
- Prior art keywords
- laccase
- promoter
- dna
- gene
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010029541 Laccase Proteins 0.000 title claims description 156
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims description 38
- 230000014509 gene expression Effects 0.000 title claims description 32
- 108090000623 proteins and genes Proteins 0.000 claims description 77
- 239000012634 fragment Substances 0.000 claims description 46
- 230000000694 effects Effects 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 29
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 27
- 239000013604 expression vector Substances 0.000 claims description 24
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 17
- 241000228245 Aspergillus niger Species 0.000 claims description 16
- 241000235058 Komagataella pastoris Species 0.000 claims description 16
- 102100022624 Glucoamylase Human genes 0.000 claims description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 13
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 12
- 244000005700 microbiome Species 0.000 claims description 11
- 230000003647 oxidation Effects 0.000 claims description 9
- 238000007254 oxidation reaction Methods 0.000 claims description 9
- 241001513093 Aspergillus awamori Species 0.000 claims description 8
- 150000001491 aromatic compounds Chemical class 0.000 claims description 8
- 108010025188 Alcohol oxidase Proteins 0.000 claims description 6
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 claims description 6
- 239000000975 dye Substances 0.000 claims description 6
- 229920005610 lignin Polymers 0.000 claims description 6
- 108090000787 Subtilisin Proteins 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 239000002351 wastewater Substances 0.000 claims description 5
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 102000013563 Acid Phosphatase Human genes 0.000 claims description 4
- 108010051457 Acid Phosphatase Proteins 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 238000004076 pulp bleaching Methods 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 101710182846 Polyhedrin Proteins 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 239000002761 deinking Substances 0.000 claims description 3
- 239000010893 paper waste Substances 0.000 claims description 3
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 2
- 102000000340 Glucosyltransferases Human genes 0.000 claims description 2
- 108010055629 Glucosyltransferases Proteins 0.000 claims description 2
- 241000588749 Klebsiella oxytoca Species 0.000 claims description 2
- 102000004139 alpha-Amylases Human genes 0.000 claims description 2
- 108090000637 alpha-Amylases Proteins 0.000 claims description 2
- 229940024171 alpha-amylase Drugs 0.000 claims description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 230000005030 transcription termination Effects 0.000 claims description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 55
- 239000013598 vector Substances 0.000 description 51
- 239000013615 primer Substances 0.000 description 45
- 239000002299 complementary DNA Substances 0.000 description 43
- 241000222355 Trametes versicolor Species 0.000 description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- 238000003776 cleavage reaction Methods 0.000 description 17
- 230000007017 scission Effects 0.000 description 17
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 239000000872 buffer Substances 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 230000009466 transformation Effects 0.000 description 14
- 241000588724 Escherichia coli Species 0.000 description 13
- 241000228212 Aspergillus Species 0.000 description 12
- 210000001938 protoplast Anatomy 0.000 description 11
- 150000001413 amino acids Chemical group 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 241000233866 Fungi Species 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 101150108358 GLAA gene Proteins 0.000 description 8
- 230000028327 secretion Effects 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 108010048241 acetamidase Proteins 0.000 description 7
- 230000002759 chromosomal effect Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000003298 DNA probe Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 108020001507 fusion proteins Proteins 0.000 description 6
- 102000037865 fusion proteins Human genes 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 101150054232 pyrG gene Proteins 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 4
- 241000221198 Basidiomycota Species 0.000 description 4
- 101001007681 Candida albicans (strain WO-1) Kexin Proteins 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- 229920002271 DEAE-Sepharose Polymers 0.000 description 4
- 108020003215 DNA Probes Proteins 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 235000010419 agar Nutrition 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 101150016309 trpC gene Proteins 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 241000351920 Aspergillus nidulans Species 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101150069554 HIS4 gene Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 3
- 101150069003 amdS gene Proteins 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 102100036826 Aldehyde oxidase Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 2
- 101150045458 KEX2 gene Proteins 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 108010084455 Zeocin Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000009295 crossflow filtration Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 108010090409 novozym 234 Proteins 0.000 description 2
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229910052573 porcelain Inorganic materials 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 238000004065 wastewater treatment Methods 0.000 description 2
- 239000007222 ypd medium Substances 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- 101150066838 12 gene Proteins 0.000 description 1
- 101150029062 15 gene Proteins 0.000 description 1
- 101150066375 35 gene Proteins 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 1
- 101100216041 Aspergillus niger GLAA gene Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101100335746 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) gapA gene Proteins 0.000 description 1
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
- TWVKGYNQQAUNRN-ACZMJKKPSA-N Ile-Ser Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O TWVKGYNQQAUNRN-ACZMJKKPSA-N 0.000 description 1
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 1
- 241001674208 Mycothermus thermophilus Species 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000222397 Phlebia radiata Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000789035 Polyporus pinsitus Species 0.000 description 1
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 1
- 108090000035 Pseudoazurin Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010001244 Tli polymerase Proteins 0.000 description 1
- 241000222357 Trametes hirsuta Species 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- KYOBSHFOBAOFBF-UHFFFAOYSA-N UMP Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1C(O)=O KYOBSHFOBAOFBF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 101150008194 argB gene Proteins 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 150000003938 benzyl alcohols Chemical class 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 101150073818 gap gene Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 230000009643 growth defect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 101150039489 lysZ gene Proteins 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 101150095344 niaD gene Proteins 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- KYOBSHFOBAOFBF-XVFCMESISA-N orotidine 5'-phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1C(O)=O KYOBSHFOBAOFBF-XVFCMESISA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0061—Laccase (1.10.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Paper (AREA)
- Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
Description
WO 98/55628 PCT/EP98/03343 DNA sequences, expression of these DNA sequences, thermophilic laccases encoded by the DNA sequences, and the use thereof 5 The invention relates to DNA sequences which code for proteins having laccase activity, to the expression of these DNA sequences, to the thermophilic laccases encoded by the DNA sequences, and to the use thereof. 10 A class of enzymes which is of great interest for industrial applications is the class of laccase enzymes (p-hydroxyphenol oxidase, EC 1.10.3.2.). Laccases are proteins belonging to the family called the "blue copper proteins" and, as a rule, contain four 15 copper ions which are disposed in three copper centers designated type 1 to type 3. Laccases are distinguished by generally being secreted proteins and by possibly having a glycosylation content, from 10 to 45% of the molecular weight. Laccases have a very broad substrate 20 specificity for aromatic compounds which they oxidize. The electrons generated in this oxidation are used to reduce oxygen. This results in water. The function of laccases, which occur in white rot fungi, is, inter alia, to break down lignin. This is also the source of 25 the interest in employing laccases in paper manufacture for delignification of pulp. Besides the depolymerization of macromolecular compounds such as lignin, laccases are also able to catalyze the polymerization in particular of aromatic 30 compounds. An example of this is the biosynthesis of lignin in plants in which the laccases occurring in plants are involved. Possible industrial applications of laccases therefore also emerge generally for polymerization reactions of all types, for example in 35 waste water treatment. The use of laccases in organic chemical synthesis is also known, for example in coupling reactions or side-chain oxidation of aromatic compounds. However, for many of these potential -2 applications it is a disadvantage that most of the known laccases are mesophilic, that is to say they have a low temperature optimum and a limited thermal stability. 5 A precondition for industrial use of laccase enzymes is that they can be prepared at reasonable cost. This is generally possible only by the use of enzymes prepared by recombinant techniques. Various prokaryotic and eukaryotic expression systems are 10 available for protein production. Examples of pro karyotic expression systems are Escherichia coli and Bacillus subtilis. Eukaryotic expression systems which are widely used are cell culture systems both of mammalian cells and of insect cells, and eukaryotic 15 microorganisms such as yeasts or filamentous fungi. WO 96/00290 describes five laccase genes from filamentous fungus of the subclass of Basidiomycetes, Polyporus pinsitus. One of these laccase genes (LCC1) was prepared as recombinant protein. The thermophilic 20 properties of this enzyme were not investigated further, but the described use of the LCC1 laccase for purposes of hair dyeing suggests that this enzyme has mesophilic characteristics.. The preparation of a recombinant laccase with 25 thermophilic properties from the filamentous fungus of the subclass of Deuteromycetes, Scytalidium thermo philum, is described in WO 95/33837. It is not known whether this enzyme is suitable for pulp bleaching. As yet, no process for preparing a thermophilic 30 laccase from a filamentous fungus of the subclass of Basidiomycetes as recombinant protein has been described. CA: AN 96-203142 discloses various characteris tics of a thermophilic laccase. No DNA or protein 35 sequence of this protein is disclosed. The invention relates to a DNA sequence which codes for a protein having laccase activity, which comprises DNA sequence SEQ ID NO: 1 from position 76 up to and including position 1572 or SEQ ID NO: 2 from -3 position 76 up to and including position 1,572 or a DNA sequence having a sequence homology of more than 80% with said DNA sequences. SEQ ID NO: 1 and SEQ ID NO: 2 represent from 5 position 1 to position 75 the DNA sequence coding for ,the signal sequence for secretion of the protein. This signal sequence can be replaced by any other signal sequences for protein secretion. The novel DNA sequence can be obtained, for 10 example, by cloning from the Basidiomycetes strain Trametes versicolor TV-1 (deposited at the DSMZ, Deutschen Sammlung von Mikrgorganismen und Zellkulturen GmbH, D-38124 Braunschweig, under the number DSM 11523) . For this purpose, a gene bank is set up 15 from Trametes versicolor TV-1 by methods known per se. This may be a cDNA or a genomic gene bank. To isolate the novel DNA sequence in the gene bank, DNA probes which contain laccase-specific DNA sequences are used. DNA probes of this type- can be 20 obtained, for example, by means of PCR reaction using DNA primers from genomic DNA from Trametes versicolor TV-1. The primers used are degenerate DNA sections with a length of, preferably, 14 to 27 bp, whose 25 sequence is established by comparison with sequences of known laccase genes. The DNA sections suitable as primers are preferably obtained by oligonucleotide synthesis of the DNA sections which have been established. 30 A novel laccase gene can be isolated, for example, as described in Examples 1 to 5. A laccase gene isolated by way of example in this way can be modified by techniques known to the skilled worker, for example of site directed muta 35 genesis, at any desired position in the sequence. The invention therefore also embraces a DNA sequence coding for a protein having laccase activity comprising a DNA sequence with a sequence homology of more than 80% with the DNA sequence SEQ ID NO: 1 from position 76 up to -4 and including position 1572 or SEQ ID NO: 2 from position 76 up to and including position 1572. To express the novel DNA, the latter is cloned in an expression vector in a manner known per se, and 5 this expression vector containing the laccase gene is introduced into a microorganism and expressed in the microorganism. The expression vector can be a DNA construct which is integrated into the genome of the host 10 organism and is replicated together with the latter. Alternatively, the expression vector may be an autonomously replicating DNA construct which does not integrate into the host genome, such as, for example, a plasmid, an artificial chromosome or a comparable 15 extrachromosomal genetic element. A suitable expression vector ought preferably to contain the following genetic elements: A promoter which promotes expression of the laccase gene in the host organism. This should 20 preferably be a strong promoter-in order to be able to ensure high expression efficiency. The promoter is preferably functionally linked to the 5' end of the laccase gene. Suitable and preferred promoters are selected 25 from the group of tac promoter, subtilisin promoter, GAL promoter, TAKA amylase promoter, polyhedrin promoter, glucoamylase promoter, gapDH promoter and alcohol oxidase promoter. Suitable and preferred for expression in 30 E. coli is the tac promoter, for expression in Bacillus is the subtilisin promoter, for expression in the yeast Saccharomyces cerevisiae is the GAL promoter, for expression in Aspergillus niger is the TAKA amylase promoter, for expression in baculovirus-infected insect 35 cells is the polyhedrin promoter, or the glucoamylase promoter from Aspergillus niger or the alcohol oxidase promoter from the yeast Pichia pastoris. Particularly suitable for expression of the novel thermophilic laccases is the glucoamylase -5 promoter from Aspergillus niger or the alcohol oxidase promoter from the yeast Pichia pastoris. The expression vector should also preferably contain signals, appropriate for the host organism, for 5 transcription termination and, in eukaryotes, addition ally signals for polyadenylation, which should be functionally linked to the 3' end of the laccase gene. The expressed protein should preferably be secreted by the host organism to the culture medium. 10 Secretion by the host organism is mediated by an N-terminal signal sequence. The signal sequence is the natural signal sequence present in the laccase gene or is a heterologous signal sequence whose coding DNA is functionally linked to the 5' end of the laccase gene 15 in the expression vector. The signal sequences of the following secreted proteins are preferred: alpha-cyclodextrin glucosyl transferase from Klebsiella oxytoca, subtilisin from Bacillus subtilis, alpha-factor from Saccharomyces 20 cerevisiae, acid phosphatase from Pichia pastoris, alpha-amylase from Aspergillus niger, glucoamylase from Aspergillus niger or from Aspergillus awamori or the signal sequence naturally present in the laccase gene. Particularly suitable are the signal sequence 25 naturally present in the laccase gene, and the following heterologous signal sequences: the signal sequence of glucoamylase from Aspergillus niger, or from Aspergillus awamori, the signal sequence of the alpha-factor from Saccharomyces cerevisiae or of the 30 acid phosphatase from Pichia pastoris. The secretion of the laccase can also be achieved by expression of a fusion protein, where a gene for a secreted protein or for a secreted fragment of this protein is functionally linked to the laccase 35 gene in the expression vector. Particularly preferred in this connection is expression of a fusion protein consisting of an N-terminal fragment of the glucoamylase from Aspergillus niger and the thermo ,-hilic laccase.
6 The point of linkage between the glucoamylase and the laccase is moreover preferably chosen so that the amino acid sequence of this point of linkage serves as recognition site for a processing peptidase in the 5 secretory apparatus of the host cell, the expressed fusion protein being cleaved in vivo and the laccase being released. The expression vector preferably also contains the gene for a selection marker. The selection markers 10 encoded by the gene can either confer resistance to an antibiotic on the host organism or complement a defect in the host organism. Preferred selection markers are genes which confer resistance to antibiotics such as ampicillin, 15 kanamycin, chloramphenicol, tetracycline, hygromycin, zeocin or bialaphos. Preferred selection markers for complementation of growth defects are genes such as amdS, pyrG, trpC, His4, niaD, argB, or hygB. Particularly suitable as selection markers are 20 amdS and the pyrG gene and the His4 gene and the resistance gene for the antibiotic zeocin. The selection marker gene can moreover be present together with the laccase gene in one DNA molecule or the two genes can be present separately in 25 different DNA molecules. In the latter case, the host organism is cotransformed with both DNA molecules together. , The invention thus also relates to expression vectors which comprise the novel DNA sequences. 30 Suitable and preferred microorganisms for expressing the novel expression vectors are those of bacterial origin such as E. coli or Bacillus subtilis, microorganisms of eukaryotic origin such as yeasts of the genus Saccharomyces or Pichia, or else filamentous 35 fungi of the genus Aspergillus, Trichoderma, Neurospora or Schyzophillum or eukaryotic cell cultures such as, for example, baculovirus-infected insect cells. Particularly suitable are filamentous fungi of the genus Aspergillus such as Aspergillus niger or 7 Aspergillus awamori or yeasts such as Saccharomyces cerevisiae or Pichia pastors. The proteins encoded by the novel DNA have the following biochemical properties: 5 The proteins have the enzymatic activity of laccases. The pH optimum of the enzyme activity is in the acidic range and is maximal at pH 2.0, with half maximal enzyme activity at pH 4.0. The enzyme stability at 450C and a pH of 4.5 to 6.0 is 100% for a period of 10 up to 2 h. The enzyme stability at 454C and-a pH of 3.0 is 50% for a period of up to 1 h. The temperature optimum at a pH of 4.5 is 70 0 C. The enzyme' activity at 65 75*C is still 80% of the maximal activity. The enzyme 15 activity at 50 - 80*C is still 50% of the. maximal activity. The enzyme stability at a pH of 4.5 and temperatures up to 55 0 C is 90% for a period of up to 2 h. The enzyme stability' at a pH of 4.5 and a temperature of 65*C is 50% for a period of up to 1 h. 20, The novel proteins comprise the protein sequence SEQ ID NO: 3. The hovel protein is preferably prepared by expressing novel DNA sequences in an abovementioned microorganism. 25 The DNA is preferably expressed using one of the abovementioned expression vectors in the micro organism. The invention thus also relates to micro organisms which comprise novel DNA sequences or novel 30 expression vectors. It is particularly preferable to use com binations of microorganisms and expression systems which also allow secretion of the protein from the microorganism. Examples of such preferred combinations 35 are: Use of the glucoamylase promoter for expressing the novel DNA sequences in Aspergillus niger or Aspergillus awamori. The secretion signal preferably used in this expression system is the signal sequence -8 of the thermophilic laccase itself or the glucoamylase portion of the glucoamylase-laccase fusion protein. Use of the alcohol oxidase promoter for expressing the novel DNA sequences in Pichia pastoris. 5 The secretion signal used in this expression system is preferably the signal sequence of the thermophilic laccase itself or the signal sequence of the alpha factor from Saccharomyces cerevisiae or of the signal sequence of the acid phosphatase from Pichia pastoris. 10 The novel proteins are suitable for all applications known for laccases. They are particularly suitable for the delignification of pulp and the depolymerization of high molecular weight aggregates. Laccases are further used in the deinking of 15 wastepaper, the polymerization of aromatic compounds in waste water treatment, in this connection particularly of lignin-containing waste waters from pulp bleaching, or in a widened application in the detoxification of contaminated soils. Further areas of use relate to the 20 oxidation of dyes and the activation of dyes by reaction with precursor components to form pigments. Areas of use in organic synthesis comprise coupling reactions of aromatic compounds or oxidation of aromatic substituents, in this connection for example 25 oxidation of benzyl alcohols to the corresponding aldehydes avoiding further oxidation to the carboxylic acid. In the abovementioned uses, the laccase can be employed on its own in the relevant reactions or else by combination with a reaction-promoting mediator. 30 Examples of such mediators are ABTS or N-hydroxybenzo triazole. The invention thus also relates to the use of a novel protein for the delignification of pulp, the depolymerization of high molecular weight aggregates, 35 the deinking of wastepaper, the polymerization of aromatic compounds in waste waters, particularly of lignin-containing waste waters from pulp bleaching, the xidation of dyes, or the activation of dyes to form ents, the use in organic synthesis for coupling 9 reactions of aromatic compounds or the oxidation of aromatic side chains. The abovementioned uses can be carried out by employing the novel laccase proteins on their own or 5 else by combination with a reaction-promoting mediator. Fig. 1 shows the structure of the DNA vector pANlaclS. Fig. 2 shows the structure of the DNA vector pANlac2S. 10 Fig. 3 shows the structure of the DNA vector pL512. Fig. 4 shows the structure of the DNA vector pL532. Fig. 5 shows the dependence of the activity of 15 a novel laccase on the pH. Fig. 6 shows the pH stability of the novel laccase. Fig. 7 shows the dependence of the activity of a novel laccase on the temperature. 20 Fig. 8 shows the temperature stability of the novel laccase. The following examples serve to illustrate the invention further. The standard methods used in the examples for treating DNA or RNA, such as treatment 25 with restriction endonucleases, DNA polymerases, reverse transcriptase etc., and the standard methods such as transformation of bacteria, Southern and Northern analysis, DNA sequencing, radiolabeling, screening and PCR technology were, unless indicated 30 otherwise, carried out as recommended by the manufacturer of the kits used or, if no manufacturer's instructions were available, in accordance with the prior art known from standard textbooks. 35 1st example: Production of a cDNA bank from Trametes versicolor TV-1 The strain Trametes versicolor TV-1 was used. Mycelium from Trametes versicolor was first obtained by culturing on malt-agar plates (3% malt extract, 0.3% - 10 peptone from soya bean meal, 1.5% agar-agar, pH 5.0) at 28 0 C for 7 days. Three pieces were punched out of the malt-agar plates and used to inoculate 100 ml of sterile malt extract medium (3% malt extract, 0.3% 5 peptone from soybean meal, pH 5.0) in 500 ml Erlenmeyer flasks. The culture was incubated at 280C, shaking at 100 rpm, for 7 days. The mycelium suspension prepared in this way was filtered with suction through a porcelain funnel, washing with 0.9% saline, and the 10 mycelium was frozen in liquid nitrogen and comminuted with pestle and mortar. RNA was isolated using an RNeasy kit (Qiagen) . The yield from 200 mg of mycelium was 100 pg of RNA. 600 pg of RNA were used to isolate mRNA. This 15 took place by chromatography on oligo-dT Sepharose (mRNA isolation kit, Pharmacia) . The yield of mRNA was 26 pg. 7.25 pg of the isolated mRNA were used to synthesize cDNA. A cDNA synthesis kit from Stratagene was used for this. After fractionation, the cDNA was 20 fractionated by agarose gel electrophoresis into a 0.8 - 2.1 kb size range and a 2.1 - 5 kb size range. The cDNA of both fractions was isolated from the agarose (Qiagen gel extraction kit) and used to produce the cDNA bank. The cDNA bank was produced in lambda phages 25 (Stratagene, ZAP Express ' cloning system). 4 x 10' phages/sg of vector DNA were obtained from the 0.8 - 2.1 kb fraction. 1 x 105 phages/pg of vector DNA were obtained from the 2.1 - 5 kb fraction. The result ing phages were amplified by infecting the E. coli 30 strain XL-1 Blue MRF' (Stratagene). 2nd example Production of a chromosomal gene bank from Trametes versicolor 35 Mycelium from Trametes versicolor TV-1 was prepared as described in the 1st example. The mycelium was filtered off with suction through a porcelain funnel and washed with 0.9% saline, then frozen in liquid nitrogen, comminuted with mortar and pestle and divided into 1 g portions. Each 1 g portion of the crushed mycelium was taken up in a sterile sample vessel and immediately mixed with 5 ml of extraction solution (0.1 M tris-HCl, pH 8.0, 0.1 M EDTA, 5 0.25 M NaCl, 0.6 mg/ml proteinase K) and 0.5 ml of a 10% (w/v) sodium lauroylsarcosine solution. After incubation at 50 0 C for at least 2 h, the mixture was mixed with 0.85 ml of 5 M NaCl and 0.7 ml of a 10% (w/v) CTAB solution in 0.7 M NaCl and incubated at 65 0 C 10 for 30 min. After addition of 7 ml of a chloroform/ isoamyl alcohol mixture (24:1), the mixture was shaken and the two phases were separated by centrifugation. The aqueous phase was removed and chromosomal DNA was precipitated by adding 0.6 part by volume of iso 15 propanol. The precipitated DNA was subsequently puri fied on a column (Qiagen Genomic Tip) . It was possible in this way to isolate 0.5 mg of chromosomal DNA from 16 g of mycelium. To produce the chromosomal gene bank, 90 pg of 20 chromosomal DNA from Trametes versicolor TV--1 were completely cut with Eco RI and fractionated by agarose gel electrophoresis. The chromosomal DNA fragments were isolated in the 2 - 4 kb and 4 kb - 10 kb size range and in each case cloned into lambda phages (Stratagene, 25 ZAP Express cloning system). 1 x 10s phages/pg of vector DNA were obtained from the 2 - 4 kb DNA fraction, and 5.4 x 104 phages/pg of vector DNA were obtained from the 4 - 10 kb DNA fraction. The phages were amplified by infecting the E. coli strain XL-1 Blue MRF'. 30 3rd example Preparation of a laccase-specific DNA probe from genomic DNA from Trametes versicolor A DNA probe for isolating laccase genes was 35 produced by PCR amplification with degenerate primers from T. versicolor genomic DNA. The degenerate primers were constructed on the basis of a comparison of sequences of known laccase genes. The amino acid sequences of the laccase genes, contained in the EMBL - 12 gene data bank, from Neurospora crassa, Coriolus hirsutus, Phlebia radiata, Agaricus bisporus and a filamentous fungus which was not characterized in detail from the subclass of Basidiomycetes were com 5 pared. It was possible through the comparison of sequences to identify four peptides with a length of 5 to 7 amino acids which were completely conserved in all the laccases. These peptides were translated back to DNA, taking account of degenerate codons, in order to 10 prepare degenerate primers. The primers had the following sequences: A: 5'-TGGCAYGGNTTYTTYCA-3' (SEQ ID NO: 4) B: 5'-TCDATRTGRCARTG-3' (SEQ ID NO: 5) C: 5'-ATTCAGGGATCCTGGTAYCAYWSNCAY-3' (SEQ ID NO: 6) D: 5'-ATACGAGGATCCRTGNCCRTGNARRTG-3' (SEQ ID NO: 7) Primers C and D contained at the 5' end a 15 Bam HI cleavage site (underlined) and, attached thereto, in each case the appropriate degenerate laccase sequence. Genomic DNA from T. versicolor was isolated from the mycelium of a shaken flask culture as 20 described in the 2nd example. PCR amplifications were carried out in accordance with the prior art familiar to the skilled worker. In a first PCR reaction, 200 ng of chromosomal T. versicolor DNA were employed in a 100 pl PCR reaction which additionally contained 1.25 U 25 of Taq polymerase, 1.25 mM MgCl 2 , 0.2 mM of each of the four dNTPs and in each case 100 pmol of primers A and B. The other conditions for the specific amplification of the required PCR product were: 5 min at 94 0 C followed by 7 cycles of 0.5 min at 94 0 C, 1 min at 40 0 C 30 and 2.5 min at 60 0 C, and 30 cycles of 0.5 min at 940C, 1 min at 50 0 C and 2.5 min at 72 0 C. 1 pl from the first PCR reaction was employed in a second PCR reaction which additionally contained 1.25 U of Taq polymerase, 1.25 mM MgCl 2 , 0.2 mM of each of the four dNTPs and, in 35 each case, 100 pmol of primers C and D. The further - 13 conditions for the specific amplication of the required PCR product were: S min at 94 0 C, followed by 7 cycles of 0.5 min at 940C, 1 min at 40 0 C and 2.5 min at 60*C, and 30 cycles of 0.5 min at 94 0 C, 1 min at 50*C and 5 2.5 min at 720C. A PCR product of about 1.1 kb was obtained. The PCR product was purified by agarose gel electrophoresis, cut with the restriction enzyme Bam HI, and cloned into a pUC18 vector cut with Bam HI and transformed into E. coli. The plasmid was isolated 10 from cultivation of transformed E. coli. DNA sequence analysis of the 5' and 3' ends confirmed that the cloned DNA fragment was the fragment of a laccase gene. To prepare the DNA probe for screening laccase genes, the laccase-specific PCR fragment was cut out by 15 treatment with Bam HI, isolated by agarose electro phoresis and radiolabeled with a- [ 32 p] -dATP (random priming kit, Boehringer Mannheim) . Free radioactivity was removed by chromatography on Sephadex G25 (Pharmacia). The specific activity of the radiolabeled 20 DNA probe was 1 x 107 cpm/pg of DNA. 4th example Isolation of the cDNA gene of a laccase from Trametes versicolor TV-1 25 The cDNA gene bank from Trametes versicolor TV-1 described in the 1st example was used. Screening for laccase cDNA genes was carried out in accordance with the prior art. In a first screening round, cells of the E. coli XL-1 Blue MRF' were first cultivated on 30 10 Petri dishes and then infected with 50,000 phages of the cDNA bank (0.8 - 2.1 kb fraction, see 1st example) per Petri dish. After incubation at 37 0 C overnight, the newly formed phages were transferred to nylon filters (Stratagene). The filters were then hybridized in 35 accordance with the manufacturer's instructions with the radiolabeled laccase-specific probe (see 3rd example). The hybridization temperature was 45C in a hybridization buffer containing 50% formamide. Positive clones were picked and purified by repetition - 14 of the screening process. After three rounds of isolation, 20 strongly hybridizing phage clones were isolated in this screening and were recloned by in vivo excision in accordance with a protocol of the 5 manufacturer (Stratagene) into the pBK CMV vector (Stratagene) . Analysis of the clones by digestion with restriction endonucleases and DNA sequencing revealed that two laccase genes which were virtually identical at the DNA level had been isolated. Complete DNA 10 sequencing of the two clones revealed that they were alleles of a laccase gene identical in amino acid sequence. The two laccase cDNA genes were called Lac5.5 and Lac5.6. Correspondingly, the plasmids with the two laccase cDNA genes were called pLac5.5 and pLac5.6. 15 5th example Isolation of the chromosomal gene of a laccase from Trametes versicolor TV-1 20 Screening for chromosomal laccase genes in the chromosomal gene bank, described in the 2nd example, from Trametes versicolor TV-1 (2 - 10 kb fraction, see 2nd example) took place in analogy to the screening for cDNA clones described in the 4th example. Once again, 25 the radiolabeled laccase-specific probe described in the 3rd example was used. The hybridization temperature was 45 0 C in a hybridization buffer containing 50% formamide. In the screening, three strongly hybridizing phage clones were isolated and were recloned by in vivo 30 excision in accordance with a protocol of the manufacturer (Stratagene) into the pBK CMV vector (Stratagene) . Analysis with restriction endonucleases led to the conclusion that all three clones were identical and had a length of about 7 kb. Analysis by 35 DNA sequencing revealed that all three clones corresponded to the chromosomal gene of the laccase Lac5.6. The coding region of a clone and, in each case, about 1 kb of flanking sequence in the 5' and 3' regions were sequenced. (SEQ ID NO: 8).
- 15 6th example Preparation of DNA constructs for the expression of laccase Lac5.5 in Aspergillus cDNA of Trametes versicolor laccase Lac5.5 was 5 functionally linked to expression signals which are specific for filamentous fungi from the Aspergillus family. The following gene expression elements from Aspergillus were used: a) The promoter for the glucoamylase gene (glaA) from 10 Aspergillus niger (J.C. Verdoes, P.J. Punt, J.M. Schrickx, H.W. van Verseveld, A.H. Stouthamer and C.A.M.J.J. van den Hondel Transgenic Research 2 (1993), 84 - 92). b) The glaA promoter followed by a DNA fragment which 15 codes for the signal sequence and a fragment of mature glucoamylase. Linked to this was a DNA sequence which codes for the cleavage site of the KEX2 protease (M.P. Broekhuijsen, I.E. Mattern, R. Contreras, J.R. Kinghorn, C.A.M.J.J. van den Hondel -(1993), 20 J. Biotechnol. 31, 135-145). c) The transcription terminator of the trpC gene from Aspergillus nidulans (E.J. Mullaney, J.E. Hamer, M.M. Yelton and W.E. Timberlake (1985), Mol. Gen. Genet. 199, 37-45). 25 However, for functional linkage of the Lac5.5 cDNA to the Aspergillus expression signals, it was first necessary to modify the 5' and 3' regions of the Lac5.5 cDNA gene. 30 A: Linkage of the laccase Lac5.5 cDNA to the glaA promoter: For further processing, the Lac5.5 cDNA gene was recloned into the vector pUC19. To this end, the Lac5.5 cDNA gene was isolated as 1.9 kb Eco RI-Xba I 35 fragment from the pBK CMV vector obtained in the 1st example and was subcloned into the pUC19 vector which had previously been cut with Eco RI and Xba I. The resulting 4.6 kb plasmid was called pLac5.
- 16 To modify the start ATG codon of the Lac5.5 cDNA gene, primers E and F were used. Primer E: 5' -CCGGAATTCATGACTGGGCTGCGTCTCCTTCCTTCCTTC-3' 5 (SEQ ID NO: 9) Primer F: 5'-GAGAGGCCCGGGAGCCTGG-3' (SEQ ID NO: 10) Underlining in primer E indicates a Bsp HI cleavage site, and in primer F indicates an Sma I or 10 Xma I cleavage site. To modify the 3' region of the Lac5.5 cDNA gene, primers G and H were used. Primer G: 5'-GCTGAATTCGAAGACATCCCCGACACCAAGG-3' (SEQ ID 15 NO: 11) Primer H: 5' - TGCTCTAGAAAGCTTAAGTTCACTGGTCGTCAGCGTCGAGGG-3' (SEQ ID NO: 12) Underlining in primer G indicates a Bbs I 20 cleavage site, and in primer H indicates an Afl II cleavage site. Primers E and F were 'used to amplify a fragment 188 bp in size in the 5' region of the Lac5.5 cDNA gene by a PCR reaction. Primers G and H were used to amplify 25 a fragment 110 bp in size in the 3' region of the Lac5.5 cDNA gene. A 100 pil PCR mixture contained in each case 10 ng of Lac5.5 cDNA (in the pBK CMV vector), 0.5 U of Tth polymerase, 1.25 mM MgCl 2 , 0.2 mM of each of the four dNTPs and 140 pmol of each of the pair of 30 primers E and F or of the pair of primers G and H. The PCR reaction was carried out under the following conditions: 5 min at 94 0 C followed by 30 cycles of 1 min at 94 0 C, 2 min at 50 0 C and 1 min at 72 0 C and finally 7 min at 72 0 C. 35 The DNA fragment from the PCR reaction with primers E and F was first cut with Eco RI and Xma I and then purified by gel electrophoresis and cloned into the vector pLac5 which had previously been cut with Eco RI and Xma I. This resulted in the vector pLac51 in - 17 which a Bsp HI cleavage site has been introduced on the ATG translation start codon. The DNA fragment from the PCR reaction with primers G and H was first cut with Eco RI and Xba I and 5 then purified by gel electrophoresis and cloned into a pUC19 vector which had previously been cut with Eco RI and Xba I. The insert about 100 bp in size was cut out of the resulting plasmid pLT5 with Bbs I and Xba I. The Bbs I - Xba I fragment was. finally cloned into the 10 vector pLac51 which had been cut with Bbs I and Xba I. This resulted in the vector pLac513 which contained a new Afl II cleavage site at the 3' end of the laccase cDNA gene. The cDNA gene for the Trametes versicolor 15 laccase Lac5.5 with the modified 5' and 3' regions was isolated by partial digestion of the plasmid pLac513 with Bsp HI. This resulted in a 2.6 kb fragment which contained the coding region of the LacS.5 cDNA gene and about 1.1 kb of the pUC19 vector. This fragment was cut 20 in a second step with Afl II, and the resulting Lac5.5 cDNA fragment 1.5 kb in size was isolated. This fragment was ligated into the Afl II - Nco I fragment 7.4 kb in size from the vector pAN52-12 which contained a fragment 4.0 kb in size of the glaA promoter from 25 Aspergillus niger, a fragment 0.7 kb in size of the trpC transcription terminator from Aspergillus nidulans and the fragment 2.7 kb in size of the pUC18 vector. The resulting vector 8.8 kb in size was called pANlaci. In pANlac1, the glaA promoter region was functionally 30 linked via an Nco I - Bsp HI intersection to the ATG translation start codon of the laccase cDNA gene B: Linkage of the laccase Lac5.5 cDNA to the glaA promoter by replacement of the N-terminal signal 35 sequence by a glucoamylase fragment To modify the region of the cDNA gene coding for the N terminus of mature laccase Lac5.5, primers I and F were used.
- 18 Primer I: 5' -CCGGAATTCGATATCCAAGCGCGGGATCGGGCCTGTGCT CGAC-3' (SEQ ID NO:13) 5 Underlining in primer I indicates an Eco RV cleavage site. To modify the 3' region of the Lac5.5 cDNA gene, primers G and H were used (see section A of this example). 10 Primers I and F were used to amplify a fragment 110 bp in size in the 5' region of the Lac5.5 cDNA gene by a PCR reaction. Primers G and H were used to amplify a fragment 110 bp in size in the 3' region of the Lac5.5 cDNA gene. The PCR reactions were carried out as 15 described in section A of this example. The DNA fragment from the PCR reaction with primers I and F was cut with Eco RI and Xma I and then purified by gel electrophoresis and cloned into the vector pLac5 which had previously been cut with Eco RI 20 and Xma I. This resulted in the vector pLac52 in which there had been inserted, in the 5' region in front of the codon for the first amino acid of the mature laccase protein, an Eco RV cleavage site followed by the codons for the amino acids of the sequence Ile Ser 25 Lys Arg (SEQ ID NO:14). This sequence is a recognition site for KEX2 protease. The 3' region of the laccase cDNA gene in the vector pLac52 was modified as described for the vector pLac5l. The insert about 100 bp in size from the PCR reaction with primers G and H 30 was cut out of the plasmid pLT5 with Bbs I and Xba I and was isolated. The Bbs I - Xba I fragment was finally cloned into the vector pLac52 which had been cut with Bbs I and Xba I. This resulted in the vector pLac523 which contained a new Afl II cleavage site at 35 the 3' end of the laccase cDNA gene. The cDNA gene for the Trametes versicolor laccase Lac5.5 with the modified 5' and 3' regions was obtained by cutting the plasmid pLac523 with Eco RV and Afl II, and isolating the resulting Lac5.5 cDNA - 19 fragment 1.5 kb in size after agarose gel electrophoresis. This fragment was ligated into the Afl II - Eco RV fragment 9.3 kb in size of the vector pAN56-9. Vector pAN56-9 contained a fragment 4.0 kb in 5 size of the glaA promoter from Aspergillus niger, followed by a fragment 2.0 kb in size which codes for a fragment of the Aspergillus niger glaA glucoamylase, a short DNA section which codes for four amino acids of the KEX2 cleavage site, a fragment 0.7 kb in size of 10 the trpC transcription terminator from Aspergillus nidulans and the fragment 2.7 kb in size of the pUC18 vector. The Eco RV and Afl II cleavage sites were arranged 3' of the KEX2 cleavage site. Transformation into E. coli resulted in a vector 10.8 kb in size which 15 was called pANlac2. In pANlac2, the coding region of the cDNA gene for the mature laccase Lac5.5 was linked to the coding region of the glucoamylase gene in such a way that, on expression, firstly a fusion protein consisting of a fragment of the glucoamylase including 20 signal sequence, of the recognition sequence for the KEX2 protease and of the complete laccase Lac5.5 was produced. On secretion, this fusion protein is cleaved by the KEX2 protease, and the mature laccase is secreted into the culture supernatant. 25 C: Incorporation of the amdS and pyrG selection markers into the vectors pANlac1 and pANlac2 pANlacl and pANlac2 were linearized by digestion of 5 pg of each of the vectors with Not I 30 overnight. This was followed by treatment with calf intestinal alkaline phosphatase, phenol/chloroform extraction and ethanol precipitation. The genes for the selection markers amdS (acetamidase) and pyrG (orotidine-5' -monophosphate decarboxylase) were present 35 on the plasmid pAN52-11 from which they could be isolated as a fragment 6.4 kb in size after digestion with Not I. 0.2 tg of each of the linearized and phosphatase-treated vectors pANlacl and pANlac2 were ligated to 0.6 ig of the isolated Not I fragment, and - 20 E.coli JM109 was transformed therewith. The plasmid DNA was prepared from ampicillin-resistant colonies from these transformations and was cut with Not I, and analyzed by agarose gel electrophoresis. 6 of 8 5 analyzed clones from the transformation with the vector pANlac1 and 5 of 7 analyzed clones from the transformation with the vector pANlac2 contained the 6.4 kb gene Not I fragment. The vectors equipped with the selection marker genes were called pANlaclS (size 10 15.3 kb, Fig. 1) and pANlac2S (size 17.2 kb, Fig. 2) . 3 of the 6 resulting pANlac1S clones contained the Not I fragment in the required orientation indicated in Fig. 1, and 1 of the 5 resulting pANlac2S clones contained the Not I fragment in the required 15 orientation indicated in Fig.2. 7th example Transformation of Aspergillus The strains of Aspergillus niger AB1.13 (pyrG~) 20 (W. van Hartingsveldt, I.E. Mattern, C.M.J. van Zeijl, P.H. Pouwels and C.A.M.J.J. van den Hondel (1987) Mol. Gen. Genet. 206, 71 - 75) and Aspergillus awamori (strain ATCC 11358) were used for the transformation. The Aspergillus transformation was carried out in 25 accordance with the prior art (P. J. Punt and C.A.J.J. van den Hondel (1992), Meth. Enzymology 216, 447-457). Aspergillus protoplasts were obtained by treating the mycelium with Novozym 234. Mycelium from one flask was suspended in 15 ml of a freshly prepared 30 and sterile-filtered solution of the lytic enzyme mixture Novozym 234 (Novo Nordisk) in OM medium (0.27 M calcium chloride, 0.6 M NaCl) in a sterile Erlenmeyer flask. The mycelium resuspended in the enzyme solution was incubated at 30*C at slow speed (80 rpm) for 1 to 35 3 h. During the incubation, the formation of the protoplasts was observed under the microscope. Freely movable protoplasts were normally seen after 1 h. After a large number of freely movable protoplasts had been obtained, they were separated from the remaining -21 mycelium by filtration through Miracloth (Calbiochem) in a glass filter and carefully washed with STC medium (1.2 M sorbitol, 50 mM calcium chloride, 35 mM NaCl, 10 mM tris-HCl, pH 7.5). Protoplasts were isolated by 5 centrifugation of the suspension in a sterile sample vessel (2000 rpm, 4*C, 10 min) and washed twice with STC medium. The protoplast concentration was determined under the microscope in a counting chamber. The protoplast suspension was adjusted to a concentration 10 of 1 x 108 protoplasts/ml for experiments for protoplast regeneration or for transformations. Protoplasts from Aspergillus niger and Aspergillus awamori were transformed with the plasmids pANlac1S and pANlac2S. Both plasmids contained the pyrG 15 gene (codes for orotidine-5'-phosphate decarboxylase) and the amdS gene (codes for acetamidase) as selection markers. 0.1 ml aliquots of the protoplasts were mixed with 10 pg of plasmid DNA in incubation vessels with a volume of 12 ml and incubated on ice for 25 min. Then 20 1.25 ml of a 60% PEG4000 solution (60% PEG4000, 50 mM calcium chloride, 10 mM tris-HCl, pH 7.5) were slowly added with repeated mixing to the transformation mixture. After incubation at 20*C for a further 20 min, the reaction vessels were filled with STC medium, mixed 25 and centrifuged at 4C for 10 min. The pellets were resuspended and plated out on selective medium osmotically stabilized with sorbitol. The plates were incubated at 30C for 7 days and checked for growth of colonies. The transformation rate on several 30 experiments was 1 - 5 transformants/ptg of plasmid DNA for Aspergillus niger, and 0.1 - 0.5 transformants/ptg plasmid DNA for Aspergillus awamori. Transformants were purified by transfer to selective plates with acetamide. Transformants with a 35 high copy number were identified by plating on selective plates with acrylamide. Acrylamide is, in contrast to acetamide, a poor substrate for the acetamidase enzyme encoded by the amdS gene and can assist growth only with transformants having a high - 22 copy number of the amdS gene. Transformants capable of functional expression of the laccase enzyme were identified by first plating them out on plates with maltodextrin, an inducer of the expression of the glaA 5 promoter, and, after growth at 28 0 C for 2 days, covered with ABTS agar (0.1% ABTS, 1% agarose, in McIllvaine buffer, pH 4.5) . Laccase-expressing transformants were indicated by formation of a green halo. Spore suspensions were prepared from transformants which 10 showed both good growth on acrylamide plates and a positive reaction in the activity test with ABTS. 8th example Expression of the Trametes versicolor laccase Lac5.5 in 15 Aspergillus Expression of laccase Lac5.5 in Aspergillus was investigated on the shaken flask scale. The following culture medium was used: a 5% (w/v) solution of maltodextrin in tap water was autoclaved for 20 min. 20 Then 1 ml of 1 M Mg sulfate, 0.5 ml of 1000 x trace element solution, 10 ml of 50 x Asp A solution and 5 ml of 10% (w/v) casamino acids were added to 500 ml of this basic medium. The 1000 x trace element solution had the following composition: 2.2 g of ZnSO 4 x 7H 2 0, 25 1.1 g of H 3
BO
3 , 0.5 g of MnCl 2 x 4H 2 0, 0.5 g of FeSO 4 x 7H 2 0, 0.17 g of CoCl 2 x 5H 2 0, 0.16 g of CuSO 4 x 5H 2 0, 0.15 g of Na 2 MoO 4 x 2H 2 0 and 5 g of EDTA were dissolved in 80 ml of H 2 0. The 50 x AspA solution had the com position: 150 g of NaNO 3 , 13 g of KCl, 38 g of KH 2
PO
4 30 were dissolved in 500 ml of H 2 0, pH 5.5 adjusted with 10 M KOH. CuSO 4 x 5H 2 0 was also added to the medium in a final concentration of 0.5 mM. For expression experiments, 50 ml of the culture medium in a 300 ml Erlenmeyer flask were 35 inoculated with 1 x 106 spores/ml. Cultivation took place in a shaking incubator at 30 0 C and 300 rpm. Samples were taken each day for one week, and the laccase activity in the culture supernatant was deter mined. The maximum laccase activity was observed with - 23 growth between 60 and 100 h, and was between 0.5 and 2.5 U/ml. The laccase activity was determined by colorimetry with the substrate ABTS (0.1 mM in the assay) in McIllvaine buffer pH 4.5 and at 37*C. 5 McIllvaine buffer was prepared by titrating a 0.1 M citric acid solution against 0.2 M Na 2
HPO
4 solution to pH 4.5. The increase in extinction at 420 nm was measured (extinction coefficient of ABTS at 420 nm: 3.6 x 104 1 x mol- 1 x cm 1 ) . 1 U of laccase activity was 10 defined as 1 ymol of ABTS substrate converted per min. 9th example Expression of the Trametes versicolor laccase Lac5.5 in Pichia pastoris 15 An expression system commercially obtainable from Invitrogen was used with the relevant expression vectors (pPIC3 and pPIC9) and Pichia pastoris strains (GS115 and KM71). The Pichia pastoris strains GS115 and KM71 are histidine-auxotrophic. The expression vectors 20 contained the promoter and terminator of the alcohol oxidase gene AOX1 from Pichia pastoris. The cDNA gene of Trametes versicolor laccase Lac5.5 was cloned between these two genetic regulatory elements. The vector pPIC9 contained, located downstream of the AOX1 25 promoter, a DNA sequence which codes for the signal sequence of the alpha-factor protein from Saccharomyces cerevisiae, followed by a short DNA section which codes for the recognition sequence Glu-Lys-Arg-Glu-Ala-Glu Ala (SEQ ID NO: 15). The vectors contained the 30 ampicillin-resistance gene for selection in E. coli. The vectors contained the HIS4 gene from Pichia pastoris for selection in Pichia pastoris. A: Construction of a laccase Lac5.5 expression vector 35 with the signal sequence of laccase Lac5.5 The plasmid pLac5.5 and primers K and L were used for amplification of the laccase gene. Primers F and G had the following sequence: - 24 Primer K: 5' -ACTCGAGAATTCACCATGACTGGGCTGCGTCTTCTTCC-3' (SEQ ID NO: 16) Primer L: 5' -ACTAGAGCGGCCGCCTATCACTGGTCGTCAGCGTCGAGGGC-3' (SEQ ID NO: 17) 5 Primer K contained the sequence for an Eco RI cleavage site (underlined) followed by the DNA sequence for the first seven amino acids of the laccase Lac5.5 signal sequence. Primer L contained the sequence for a 10 Not I cleavage site (underlined) followed by, in complementary and reverse orientation, the translation stop codon and the DNA sequence for the last 7 amino acids of the laccase Lac5.5. PCR amplifications were carried out in 15 accordance with the prior art familiar to the skilled worker. 20 ng of pLac5.5 DNA were employed in a 50 pl PCR reaction which additionally contained 0.5 U of Vent polymerase, 1 mM MgCl 2 , 0.2 mM of each of the four dNTPs and in each case 100 pmol of primers K and .L. The 20 other conditions for the specific amplification of the required PCR product were: 5 min at 94 0 C followed by 25 cycles of 1 min at 94 0 C, 1 min at 55 0 C and 2 min at 72 0 C. The expected PCR fragment with a size of 1.5 kb was obtained. The PCR fragment was purified by agarose 25 gel electrophoresis, cut with the restriction enzymes Eco RI and Not I, precipitated with ethanol and taken up in H 2 0. The vector pPIC3 was cut with Eco RI and Not I, purified by agarose gel electrophoresis, isolated and treated with alkaline phosphatase. This 30 was followed by extraction with phenol/chloroform (ratio 3:1) and an ethanol precipitation. The DNA fragment of the laccase Lac5.5 prepared by PCR amplification was ligated into the pPIC3 vector prepared in this way, and E. coli Top 10F' cells 35 (Invitrogen) were transformed therewith. The plasmid DNA was isolated from ampicillin-resistant clones, and the cloned 1.5 kb insert was identified by restriction digestion with Eco RI and Not I. 9 of 12 investigated -25 clones were positive. The vector obtained in this way was given the name pL512 (Fig. 3). B: Construction of a laccase Lac5.5 expression vector 5 with the signal sequence of the alpha-factor from Saccharomyces cerevisiae The plasmid pLac5.5 and primers L and M were used to amplify the laccase gene. Primer M had the following sequence: 10 Primer M: 5' -ACTCGAGAATTCGGGATCGGGCCTGTGCTCGACCTCACG-3' (SEQ ID NO: 18) Primer M contained the sequence for an Eco RI 15 cleavage site (underlined) followed by the DNA sequence for the first nine amino acids of the presumed N terminus of the processed laccase Lac5.5. The N terminus of the processed laccase Lac5.5 had been deduced from comparison with other laccase sequences. 20 The DNA fragment for the processed form of the laccase Lac5.5 was prepared as described in section A of this example by PCR amplification with pLac5.5 cDNA and primers L and M. The vector pPIC9 was cut with Eco RI and Not I and prepared like the pPIC3 vector 25 described in section A of this example, and was ligated to the DNA fragment of the laccase Lac5.5 prepared by PCR amplification, and E. coli Top 1OF' cells (Invitrogen) were transformed therewith. The plasmid DNA was isolated from ampicillin-resistant clones, and 30 the cloned 1.5 kb insert was identified by restriction digestion with Eco RI and Not I. 3 of 12 investigated clones were positive. The vector obtained in this way was given the name pL532 (Fig. 4). 35 C: Transformation of Pichia pastoris Pichia pastoris strains GS115 and KM71 were first cultivated in 5 ml of YPD medium (1% yeast extract, 2% peptone, 2% dextrose) at 30 0 C overnight. 0.2 ml portions of this preculture were used to -26 inoculate two main cultures each of 250 ml of YPD medium, and cultivation was again carried out at 30*C overnight until the optical density (OD600 nm) was 1.3 - 1.5. The yeast cells from a 250 ml main culture were 5 then centrifuged down (1500 x g for 5 min), washed twice with 200 ml of H 2 0 each time and once with 10 ml of 1 M sorbitol and finally taken up in 0.5 ml of 1 M sorbitol. Plasmid DNA of the vectors pL512 or pL532 were 10 linearized either with Stu I or with Nsi I, precipi tated with ethanol and taken up in H20 in a concen tration of 1 pg of DNA per pl. A transformation mixture contained 80 pl of Pichia pastoris cells and 10 pg of linearized vector DNA. Transformation took place by 15 electroporation at 1500 V, 25 pF and 200 Ohm (BioRad Gene Pulser) . The discharge time was about 4.2 msec. 1 ml of 1 M sorbitol was added to the transformation mixture, which was incubated on ice for 30 min and then plated out in 0.3 ml aliquots on MD plates without 20 histidine (1.34% YNB, yeast nitrogen base, 4 x 10-s% biotin, 1% dextrose, 1.5% agar) . Transformants appeared after incubation at 30*C for 3 - 5 days. Transformants were purified by streaking twice on MD plates. Laccase producers were identified on MM indicator plates. MM 25 indicator plates contained 1.34% YNB, 4 x 10-s% biotin, 0.5% methanol, 1.5% agar, 1 mM ABTS and 0.1 mM Cu sulfate. The inducer methanol was placed in the lid of the Petri dishes and was renewed each day in order to ensure the colonies were supplied with methanol by 30 diffusion. Laccase producers generated a green halo after incubation at 30*C for 2 - 3 days. E: Expression in shaken flasks: 50 ml of BMGY medium (1% yeast extract, 2% 35 peptone, 0.1 M K phosphate, pH 6.0, 1.34% YNB, 4 x 10-s% biotin, 1% glycerol) were inoculated with a laccase producing Pichia pastoris transformant and cultivated on a shaker at 300 rpm and 28*C for 48 h. The cells from this preculture were isolated by centrifugation - 27 (1500 x g for 10 min) and suspended in 10 ml of main culture medium (MMY, 1% yeast extract, 2% peptone, 1.34% YNB, 4 x 10-s% biotin, 3% methanol). MMY medium was supplemented with 0.5 mM Cu sulfate, and the main 5 culture was cultivated further on a shaker at 300 rpm and room temperature. The main culture was supplemented with methanol (0.3 ml/10 ml of medium) at intervals of 24 h. Production of the recombinant laccase Lac5.5 started after 24 h. Production rates of up to 4 U/ml 10 were reached 190 h after starting the main culture. 10th example Isolation of recombinant laccase Lac5.5 Recombinant laccase Lac5.5 was obtained by 15 culturing transformed Aspergillus strains in shaken flasks as described in the 8th example. Culture supernatants containing laccase Lac5.5 were concen trated by cross-flow filtration. Sartocon micro filtration modules (Sartorius) with an exclusion' limit 20 of 30 kD were used for this. Concentrated laccase Lac5.5 was then lyophilized and dissolved in 20 mM Na phosphate, pH 6.0. The activity of the concentrated recombinant laccase LacS.5 was 18.6 U/ml. Laccase concentrated by cross-flow filtration 25 was dialyzed against 20 mM bistris-HCl, pH 6.5. A conductivity of 1.5 mS/cm was measured after this. Dialyzed laccase was then chromatographed on a column of DEAE-Sepharose (Pharmacia), equilibrated in 20 mM bistris-HCl (loading buffer), pH 6.5. Under these 30 conditions, the laccase binds to the DEAE-Sepharose. On elution with a linear gradient from 0 to 0.5 M NaCl in loading buffer, the laccase activity was recovered at a salt concentration of 0.15 M NaCl. The laccase fraction from the DEAE-Sepharose column was mixed with ammonium 35 sulfate to 20% saturation and with Na acetate, pH 4.5 (final concentration 20 mM)), and the pH was adjusted to 4.5 with acetic acid. The laccase fraction prepared in this way was then chromatographed on a column of phenyl-Sepharose (Pharmacia) equilibrated in loading - . - 28 buffer (20 mM Na acetate, pH 4.5, 20% saturated ammonium sulfate) . Under these conditions, the laccase binds to the phenyl-Sepharose. On elution with a linear gradient of 20 - 0% saturated ammonium sulfate in 20 mM 5 Na acetate, pH 4.5, the laccase activity was recovered at an ammonium sulfate saturation of 16%. The laccase fraction was dialyzed against 20 mM bistris-HCl, pH 6.5, and concentrated by binding to DEAE-Sepharose and subsequent stepped elution with 0.3 M NaCl. Binding 10 and elution with 0.3 M NaCl each took place in 20 mM bistris-HCl, pH 6.5. The yield of laccase activity based on the starting material was 20%. The isolated laccase was analyzed by N-terminal amino acid sequencing. The sequence determined thereby, 15 Gly Ile Gly Pro Val Leu Asp Leu Thr Ile Ser Arg Ala Val (SEQ ID NO: 19), was in agreement with the N terminus of mature --accase 20 Lac5.5 derived from the cDNA sequence and homology comparisons. 11th example Biochemical properties of recombinant laccase Lac5.5 25 The pH and temperature optimum and the pH and temperature stability of recombinant laccase Lac5.5, prepared in Aspergillus as described in the 8th example, were investigated. For these experiments, the recombinant laccase Lac5.5 buffer was first changed to 30 McIllvaine buffer, pH 4.5, on Sephadex G25 (Pharmacia, PD10 columns). A: pH optimum: The buffers appropriate for each of the pH 35 values indicated in Fig. 5 were prepared by suitable mixing of unbuffered Na citrate and Na phosphate solutions. The laccase activity of recombinant laccase Lac5.5 was then determined at each pH at 37 0 C. As is evident from Fig. 5, the laccase Lac5.5 has an activity - 29 optimum in the strongly acidic range for the substrate ABTS. B: pH stability: 5 Laccase Lac5.5 was preincubated in McIllvaine buffer at pH 3.0, 4.5 and 6.0 (temperature 37*C). Aliquots were taken after 0, 30, 60 and 120 min and diluted in McIllvaine buffer, pH 4.5, and the laccase activity was determined at 37*C. The laccase activity 10 was not adversely affected by the pretreatment at pH 4.5 and 6.0. The half-life of the laccase at pH 3.0 was between 60 and 120 min (Fig. 6). C: Temperature optimum: 15 The laccase activity of the recombinant laccase Lac5.5 was determined at the temperatures indicated in Fig. 7. The laccase activity was determined using the ABTS assay in McIllvaine buffer, pH 4.5. Surprisingly, it was found from this that the temperature optimum of 20 the laccase Lac5.5 is 700C. The temperatures at which the measured laccase activity is still half the maximum were 500C and 800C. D: Temperature stability: 25 Laccase Lac5.5 was preincubated in McIllvaine buffer, pH 4.5, at 45, 55 and 650C. Aliquots were taken after 0, 30, 60 and 120 min and diluted in McIllvaine buffer, pH 4.5, and the laccase activity was determined at 37 0 C. The laccase activity was not adversely 30 affected by the pretreatment at 45WC. Measurement after preincubation at 55*C for 120 min showed 80% activity still remaining. The laccase half-life at 65C was 60 min (Fig. 8).
Claims (10)
1. A DNA sequence which codes for a protein having laccase activity, which comprises DNA sequence 5 SEQ ID NO: 1 from position 76 up to and including position 1572 or SEQ ID NO: 2 from position 76 up to and including position 1572 or a DNA sequence having a sequence homology of more than 80% with said DNA sequences. 10
2. An expression vector which comprises a DNA sequence as claimed in claim 1.
3. An expression vector as claimed in claim 2, which additionally comprises: a promoter which mediates expression of the laccase gene in a host organism, and 15 signals for transcription termination which are appropriate for the host organism and are functionally linked to the 3' end of the DNA sequence as claimed in claim 1.
4. An expression vector as claimed in claim 3, 20 wherein the promoter is selected from the group of tac promoter, subtilisin promoter, GAL promoter, TAKA amylase promoter, polyhedrin promoter, glucoamylase promoter, GAPDH promoter and alcohol oxidase promoter.
5. An expression vector as claimed in claim 3 or 25 4, which additionally comprises an N-terminal signal sequence.
6. An expression vector as claimed in claim 5, wherein the N-terminal signal sequence is the natural signal sequence present in the laccase gene, or is 30 selected from the group of signal sequences of the following secreted proteins: alpha-cyclodextrin glucosyltransferase from Klebsiella oxytoca, subtilisin from Bacillus subtilis, alpha-factor from Saccharomyces cerevisiae, acid phosphatase from Pichia pastoris, 35 alpha-amylase from Aspergillus niger or glucoamylase from Aspergillus niger or from Aspergillus awamori.
7. An expression vector as claimed in claim 5, wherein a gene for a secreted protein or a gene section for secreted fragment of a protein is functionally linked to the laccase gene.
8. A microorganism strain which comprises a DNA sequence as claimed in claim 1 or an expression vector 5 as claimed in any of claims 2 to 7.
9. A protein comprising the protein sequence SEQ ID NO: 3.
10. The use of the protein as claimed in claim 9 for the delignification of pulp, the depolymerization 10 of high molecular weight aggregates, the deinking of wastepaper, the polymerization of aromatic compounds in waste waters, particularly of lignin-containing waste waters from pulp bleaching, the oxidation of dyes, or the activation of dyes to form pigments, the use in 15 organic synthesis for coupling reactions of aromatic compounds or the oxidation of aromatic side chains.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19724039 | 1997-06-06 | ||
| DE19724039A DE19724039A1 (en) | 1997-06-06 | 1997-06-06 | DNA sequences, expression of these DNA sequences, thermophilic laccases encoded by the DNA sequences and their use |
| PCT/EP1998/003343 WO1998055628A2 (en) | 1997-06-06 | 1998-06-04 | Dna sequences, expression of said dna sequences, thermopile laccases coded by said dna sequences and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8624698A true AU8624698A (en) | 1998-12-21 |
| AU725639B2 AU725639B2 (en) | 2000-10-19 |
Family
ID=7831772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU86246/98A Ceased AU725639B2 (en) | 1997-06-06 | 1998-06-04 | DNA sequences, expression of these DNA sequences, thermophilic laccases encoded by the DNA sequences, and the use thereof |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0994950A2 (en) |
| JP (1) | JP2000513588A (en) |
| KR (1) | KR20010013482A (en) |
| CN (1) | CN1259166A (en) |
| AU (1) | AU725639B2 (en) |
| BR (1) | BR9815544A (en) |
| CA (1) | CA2292723A1 (en) |
| DE (1) | DE19724039A1 (en) |
| ID (1) | ID23856A (en) |
| NO (1) | NO995948L (en) |
| NZ (1) | NZ501312A (en) |
| PL (1) | PL337465A1 (en) |
| WO (1) | WO1998055628A2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19934408A1 (en) * | 1999-07-22 | 2001-01-25 | Consortium Elektrochem Ind | New fungal orotic acid phosphoribosyltransferase gene, useful as a selection marker in recombinant protein expression systems |
| FI113879B (en) | 2000-05-23 | 2004-06-30 | Valtion Teknillinen | A new coating enzyme |
| CN100351382C (en) * | 2004-03-04 | 2007-11-28 | 深圳市构思生物技术有限公司 | Expression carrier of laccase, microorganism strain of expression, laccase protein of expression and application thereof |
| US8264669B2 (en) | 2007-07-24 | 2012-09-11 | Nikon Corporation | Movable body drive method, pattern formation method, exposure method, and device manufacturing method for maintaining position coordinate before and after switching encoder head |
| CN102260643B (en) * | 2011-06-08 | 2014-08-06 | 中国科学院上海高等研究院 | Recombinant Klebsiells pneumobacillus resistant to phenolic substances, preparation method and application thereof |
| EP4361274A4 (en) | 2021-06-23 | 2025-06-18 | Amano Enzyme Inc. | LACCASE |
| WO2022270590A1 (en) | 2021-06-23 | 2022-12-29 | 天野エンザイム株式会社 | Laccase |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69528061T2 (en) * | 1994-06-24 | 2003-04-30 | Novozymes A/S, Bagsvaerd | PURIFIED POLYPORUS LACCASES AND ENCODING NUCLEIC ACIDS |
-
1997
- 1997-06-06 DE DE19724039A patent/DE19724039A1/en not_active Ceased
-
1998
- 1998-06-04 CA CA002292723A patent/CA2292723A1/en not_active Abandoned
- 1998-06-04 EP EP98937446A patent/EP0994950A2/en not_active Withdrawn
- 1998-06-04 BR BR9815544-0A patent/BR9815544A/en not_active IP Right Cessation
- 1998-06-04 PL PL98337465A patent/PL337465A1/en not_active Application Discontinuation
- 1998-06-04 WO PCT/EP1998/003343 patent/WO1998055628A2/en not_active Ceased
- 1998-06-04 KR KR1019997011486A patent/KR20010013482A/en not_active Ceased
- 1998-06-04 ID IDW991457A patent/ID23856A/en unknown
- 1998-06-04 JP JP11501520A patent/JP2000513588A/en active Pending
- 1998-06-04 NZ NZ501312A patent/NZ501312A/en unknown
- 1998-06-04 AU AU86246/98A patent/AU725639B2/en not_active Ceased
- 1998-06-04 CN CN98805778A patent/CN1259166A/en active Pending
-
1999
- 1999-12-03 NO NO995948A patent/NO995948L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998055628A3 (en) | 1999-03-04 |
| BR9815544A (en) | 2001-11-06 |
| CN1259166A (en) | 2000-07-05 |
| ID23856A (en) | 2000-05-25 |
| CA2292723A1 (en) | 1998-12-10 |
| EP0994950A2 (en) | 2000-04-26 |
| KR20010013482A (en) | 2001-02-26 |
| DE19724039A1 (en) | 1998-12-10 |
| JP2000513588A (en) | 2000-10-17 |
| WO1998055628A2 (en) | 1998-12-10 |
| PL337465A1 (en) | 2000-08-14 |
| NO995948L (en) | 2000-02-07 |
| NZ501312A (en) | 2000-09-29 |
| AU725639B2 (en) | 2000-10-19 |
| NO995948D0 (en) | 1999-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5965384A (en) | Methods for producing Humicola lipases in aspergillus | |
| US5863759A (en) | Process for the production of protein products in aspergillus | |
| AU718990B2 (en) | Lysophospholipase produced from Aspergillus by recombinant methods | |
| JPH09503126A (en) | Purification ▲ pH ▼ Neutral Rhizoctonia laccase and nucleic acid encoding the same | |
| OA10123A (en) | Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein | |
| EP0956338A1 (en) | Novel host cells and methods of producing proteins | |
| EP0804558A2 (en) | Tripeptidyl aminopeptidase | |
| IE880292L (en) | Novel expression system | |
| US8609386B2 (en) | Polypeptides having tyrosinase activity and polynucleotides encoding same | |
| AU725639B2 (en) | DNA sequences, expression of these DNA sequences, thermophilic laccases encoded by the DNA sequences, and the use thereof | |
| NO315379B1 (en) | Isolated DNA molecule, hybrid vector, Aspergillus niger strain, Aspergillus niger serine protease, method for producing a desired polypeptide and all transformed with a hybrid expression vector | |
| Yeo et al. | Generation of a transformant showing higher manganese peroxidase (Mnp) activity by overexpression of Mnp gene in Trametes versicolor | |
| US6551797B1 (en) | Expression system for producing proteins | |
| Li et al. | Homologous expression of recombinant cellobiose dehydrogenase in Phanerochaete chrysosporium | |
| US7001751B1 (en) | PyrF gene and the utilization thereof | |
| AU690617B2 (en) | (Aspergillus foetidus) expression system | |
| KR101309061B1 (en) | Tannic acid-degradable laccase 3 of Cryphonectria parasitica and usage thereof | |
| AU8341098A (en) | Increased production of secreted proteins by recombinant yeast cells | |
| CN111690622B (en) | Laccase g2589 derived from fungi as well as gene and application thereof | |
| Yamazaki et al. | Isolation of a ras gene from the basidiomycete Coriolus hirsutus and use of its promoter for the expression of Pleurotus ostreatus manganese (II) peroxidase cDNA in C. hirsutus | |
| EP1029922A2 (en) | DNA fragments having basidiomycete-derived promoter activity and their use | |
| Stewart | Genomic organization and expression of the lignin peroxidase genes of Phanerochaete chrysosporium | |
| Yamazaki et al. | Isolation of arasgene from the basidiomyceteCoriolus hirsutusand use of its promoter for the expression ofPleurotus ostreatusmanganese (II) peroxidase cDNA inC. hirsutus. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |